Consensus Clinical Management Guideline for PLA2G6-Associated Neurodegeneration (PLAN)

  • Jenny L. Wilson
  • , Audrey K.S. Soo
  • , Allison Gregory
  • , Nardo Nardocci
  • , Giovanna Zorzi
  • , Matthew Ritzman
  • , Amanda Hope
  • , David W. Duncan
  • , Megan Thomas
  • , Serena Bertoldi
  • , Natale A. Scalise
  • , Patricia Wood
  • , Heather Massey
  • , Amber Denton
  • , Amanda Sargent
  • , Leena Panwala
  • , Penelope Hogarth
  • , Manju A. Kurian
  • , Susan J. Hayflick

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

This clinical guideline provides recommendations for the evaluation and management of individuals with PLA2G6-associated neurodegeneration (PLAN). PLAN, a neurodegeneration with brain iron accumulation disorder, presents with infantile-onset (infantile neuroaxonal dystrophy), juvenile-onset, and adult-onset forms with motor, cognitive, ophthalmologic, and autonomic symptoms. This guideline was developed using a modified Delphi process with input from PLAN experts and family members of individuals with PLAN. A literature search was performed, although in the absence of data, recommendations were based on expert opinion. The guideline contains recommendations on diagnostic approach, disease-specific treatment, and symptom-based management.

Original languageEnglish (US)
Pages (from-to)415-432
Number of pages18
JournalJournal of child neurology
Volume40
Issue number6
DOIs
StatePublished - Jul 1 2025

Keywords

  • developmental disability
  • genetics
  • neurodevelopment
  • pediatric
  • treatment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Consensus Clinical Management Guideline for PLA2G6-Associated Neurodegeneration (PLAN)'. Together they form a unique fingerprint.

Cite this